The Institute of Microbiology and Japan’s DNAVEC Corporation signed an agreement on April 1, 2008 in Beijing to conduct a joint preclinical research on avian influenza viruse (AIV) vaccines.
Avian influenza is an infection caused by avian influenza viruses. Outbreaks of highly pathogenic avian influenza associated with illness and death in humans have occurred in Asia since late 2003. Some virus strains have evolved to become more deadly and be able to infect more species. This situation has attracted more and more concern throughout the world. The collaborative research between IMCAS and DNAVEC may shed new light to the prevention of avian influenza pandemic.